Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Relugolix does not significantly delay onset of castration resistance in prostate cancer,

A secondary analysis of the phase 3 HERO trial showed that relugolix … Garneau Chair in Prostate Cancer Research, director of clinical research, …, A secondary analysis of the phase 3 HERO trial showed that relugolix … Garneau Chair in Prostate Cancer Research, director of clinical research, …, Read More

Scroll to Top